NCT03789643View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

June 30, 2021

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

JTT-251

Active drug tablets containing JTT-251

DRUG

Placebo

Placebo tablets matching in appearance to the active drug tablets

Sponsors

Lead Sponsor

Akros Pharma Inc.
All Listed Sponsors
lead

Akros Pharma Inc.

INDUSTRY

NCT03789643 - Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter